<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7149978\results\search\tropicalVirus\results.xml">
  <result pre="and Reemerging Viral Pathogens pmcid: 7149978B978-0-12-819400-3.00016-8 doi: 10.1016/B978-0-12-819400-3.00016-8 : Article" exact="Dengue" post="Virus MurugesanAmudhanManoharanMythreyee[], EnnajiMoulay Mustapha[], pmc-release: 2019-9-9ppub: 2020epub: 2019-9-9281359(C) Elsevier"/>
  <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Dengue" post="virus (DENV) belongs to the family Flaviviridae, genus Flavivirus."/>
  <result pre="includes other arthropod borne viruses such as yellow fever virus," exact="West Nile" post="virus, Zika virus, tick-borne encephalitis virus. It infects ~50–200"/>
  <result pre="borne viruses such as yellow fever virus, West Nile virus," exact="Zika" post="virus, tick-borne encephalitis virus. It infects ~50–200 million people"/>
  <result pre="also viral evolution. There are four antigenically different serotypes of" exact="DENV" post="based on the differences in their viral structural and"/>
  <result pre="on the differences in their viral structural and nonstructural proteins." exact="DENV" post="infection causes a spectrum of illness ranging from asymptomatic"/>
  <result pre="main stay of prevention is vector control and management. Keywords" exact="Dengue" post="Flavivirus epidemiology dengue hemorrhagic fever dengue shock syndrome vaccine"/>
  <result pre="CM convoluted membrane CS complementary sequence DALYs disability-adjusted life years" exact="DENV" post="dengue virus DF dengue fever DHF dengue hemorrhagic fever"/>
  <result pre="upstream AUG region UTR untranslated region VPs vesicle packets Introduction" exact="Dengue" post="viruses (DENVs) form dengue complex in genus Flavivirus, family"/>
  <result pre="family Flaviviridae, and consists of four antigenically related but distinct" exact="DENV" post="serotypes (DENV-1, DENV-2, DENV-2, DENV-3, and DENV-4). These DENV"/>
  <result pre="distinct DENV serotypes (DENV-1, DENV-2, DENV-2, DENV-3, and DENV-4). These" exact="DENV" post="can cause a spectrum of illness ranging from asymptomatic"/>
  <result pre="in dengue drug and vaccine development. Evolution and Discovery of" exact="Dengue" post="Virus All four DENV original serotypes have similar natural"/>
  <result pre="vaccine development. Evolution and Discovery of Dengue Virus All four" exact="DENV" post="original serotypes have similar natural histories, including an enzootic"/>
  <result pre="by the fact that several mosquito-borne flaviviruses (MBFV) [Koutango, Saboya," exact="West Nile," post="and yellow fever (YF)] have all been isolated from"/>
  <result pre="complex to five serotypes (Normile, 2013). Evolution and Spread of" exact="Dengue" post="Virus Vector Aedes aegypti is most likely of African"/>
  <result pre="has been known ever since (Gubler, 2014). Mosquito Transmission of" exact="Dengue" post="Viruses With documentation that YF was transmitted by mosquitoes"/>
  <result pre="ill with DF. Factors Responsible for the Global Resurgence of" exact="Dengue" post="Disease such as dengue was not considered a major"/>
  <result pre="populations, no effective mosquito control, and are hyperendemic, with multiple" exact="DENV" post="serotypes cocirculating. The DENVs have fully adapted to humans,"/>
  <result pre="(Fig. 16.1 ). Figure 16.1 Global dengue burden. Economic Burden" exact="Dengue" post="represents a substantial economic and disease burden to communities"/>
  <result pre="dengue (Shepard et al., 2014). Taxonomy and Evolutionary Relationship of" exact="Dengue" post="With Other Flaviviruses The flaviviruses form a well-defined genus"/>
  <result pre="(DENV), the genus contains YF virus (YFV), Japanese encephalitis virus," exact="West Nile" post="virus (WNV), and tick-borne encephalitis viruses. The Flavivirus genus"/>
  <result pre="et al., 2011, Wahala and Silva, 2011). Molecular Architecture of" exact="Dengue" post="Virus In recent years a great deal of research"/>
  <result pre="Virus In recent years a great deal of research on" exact="DENV" post="biology has provided an enormous amount of information about"/>
  <result pre="important advance has been the development of genomic and subgenomic" exact="DENV" post="RNAs containing reporter genes, such as luciferase or green"/>
  <result pre="activity as a function of time after RNA transfection. Mature" exact="DENV" post="particles have a diameter of ~500 Å with an"/>
  <result pre="prM protein during viral. Overview of the Viral Life Cycle" exact="DENV" post="enters host cells by receptor-mediated endocytosis, which involves binding"/>
  <result pre="receptor-mediated endocytosis, which involves binding of E to cellular receptors." exact="DENV" post="must recognize a ubiquitous cell surface molecule or utilize"/>
  <result pre="lectin domain family 5, member A (Chen et al., 2008a)" exact="DENV" post="enters mosquito and human cells through clathrin-mediated endocytosis (Krishnan"/>
  <result pre="and human cells through clathrin-mediated endocytosis (Krishnan et al., 2007)." exact="DENV" post="particles diffuse along the cell surface toward a preexisting"/>
  <result pre="of mature, immature, and partially mature particles. Genomic Structure of" exact="Dengue" post="Virus The DENV genome consists of a single, positive-strand"/>
  <result pre="and partially mature particles. Genomic Structure of Dengue Virus The" exact="DENV" post="genome consists of a single, positive-strand RNA of ~11"/>
  <result pre="for viral replication. The 5′ UTR sequences of the four" exact="DENV" post="serotypes (DENV-1 to DENV-4) are between 95 to 101"/>
  <result pre="DENV-1 to ~385 nucleotides in DENV-4. An important feature of" exact="DENV" post="and other flavivirus genomes is the presence of inverted"/>
  <result pre="of predicted RNA elements at the 3′ UTR of the" exact="DENV" post="genome. DENV, Dengue virus; RNA, ribonucleic acid; UTR, untranslated"/>
  <result pre="elements at the 3′ UTR of the DENV genome. DENV," exact="Dengue" post="virus; RNA, ribonucleic acid; UTR, untranslated regions. Figure 16.3"/>
  <result pre="of the translation initiator AUG at the 5′ UTR of" exact="DENV" post="was found to be complementary to a region present"/>
  <result pre="5′–3′ CS were found to be also important for efficient" exact="DENV" post="replication. These sequences were named 5′–3′ downstream AUG region"/>
  <result pre="Atomic force microscopy showed that long-range RNA–RNA interaction occurs in" exact="DENV" post="genome (Alvarez et al., 2005b), also it showed that"/>
  <result pre="genome (Alvarez et al., 2005b), also it showed that full-length" exact="DENV" post="genomic RNA occurred in linear and circular conformations. 5′"/>
  <result pre="5′ Untranslated Region Alignment of the 5′ UTRs from different" exact="DENV" post="serotypes shows high sequence conservation. RNA-folding predictions of these"/>
  <result pre="are separated by a short oligo(U) sequence. SLA portion of" exact="DENV" post="genome shows three helical regions (S1, S2, and S3),"/>
  <result pre="the SLB structures, there is an oligo(U) track conserved in" exact="DENV" post="and other flavivirus genomes that functions as spacer that"/>
  <result pre="region hairpin (cHP); and (3) an RNA element that modulates" exact="DENV" post="replication in mosquito and mammalian cells (Fig. 16.3). The"/>
  <result pre="nucleotides long (134-UCAAUAUGCUG) and is absolutely conserved among the four" exact="DENV" post="serotypes. This region mediates long-range RNA–RNA interactions between the"/>
  <result pre="coding sequence were found to play a regulatory role in" exact="DENV" post="replication (Polacek et al., 2009). Mutations and deletions within"/>
  <result pre="within a predicted hairpin (CCR1) resulted in important defects in" exact="DENV" post="replication in mosquito and mammalian cells (Fig. 16.3). 3′"/>
  <result pre="16.3). 3′ Untranslated Region The 3′ UTRs of the four" exact="DENV" post="genomes contain highly conserved RNA elements (Shurtleff et al.,"/>
  <result pre="few nucleotide variations in this region. Altered sHP formation impaired" exact="DENV" post="replication (Villordo et al., 2010). The TL of the"/>
  <result pre="2010). The TL of the large terminal stem loop in" exact="DENV" post="has a highly conserved ACAGAAC sequence. In DENV the"/>
  <result pre="loop in DENV has a highly conserved ACAGAAC sequence. In" exact="DENV" post="the 3′ SL contains a total of 93 nucleotides."/>
  <result pre="Figure 16.4 Long-range RNA interactions between the ends of the" exact="DENV" post="genome. DENV, Dengue virus; RNA, ribonucleic acid. Viral Replication"/>
  <result pre="RNA interactions between the ends of the DENV genome. DENV," exact="Dengue" post="virus; RNA, ribonucleic acid. Viral Replication Replication of DENV"/>
  <result pre="DENV, Dengue virus; RNA, ribonucleic acid. Viral Replication Replication of" exact="DENV" post="is associated with a dramatic rearrangement of host cellular"/>
  <result pre="the ER origin of the VPs and CMs induced during" exact="DENV" post="infection. CMs have been proposed as putative sites for"/>
  <result pre="a new viral particle (Fig. 16.5 ). Figure 16.5 The" exact="DENV" post="life cycle. Nonstructural Proteins NS1 (48–50 kDa glycoprotein) (Muller"/>
  <result pre="highly immunogenic and is involved in stimulating protective response against" exact="DENV" post="(Mackenzie et al., 1996). It has been implicated in"/>
  <result pre="2006, Lodeiro et al., 2009). The N-terminal of NS5 from" exact="DENV" post="is shown to possess guanine N7 and ribose 2′-O"/>
  <result pre="by binding and promoting STAT2 degradation (Ashour et al., 2009)." exact="DENV" post="RNA synthesis requires specific interaction of NS5 with the"/>
  <result pre="to promote RNA synthesis in vitro (Filomatori et al., 2006)" exact="DENV" post="NS5 binds to the promoter SLA mainly through the"/>
  <result pre="et al., 2011) Crystallographic structures for the RdRp domain of" exact="WNV" post="and DENV (serotype 3) (Egloff et al., 2007, Yap"/>
  <result pre="2011) Crystallographic structures for the RdRp domain of WNV and" exact="DENV" post="(serotype 3) (Egloff et al., 2007, Yap et al.,"/>
  <result pre="An unexpected observation in the structure of the RdRp from" exact="DENV" post="was the presence of two zinc ions in the"/>
  <result pre="mechanism of fusion of E protein leads to internalization of" exact="DENV" post="has been proposed by (Modis et al., 2004) and"/>
  <result pre="and structural proteins of dengue in replication complex. Pathogenesis of" exact="Dengue" post="Viral Factors Viral virulence is influenced by viral genetics"/>
  <result pre="host genetics (factors that are &quot;extrinsic�? to the virus). Certain" exact="DENV" post="strains demonstrate greater epidemic potential, as they replicate better"/>
  <result pre="hypothesis (Rosen, 1977) and is supported by the several studies." exact="DENV" post="virulence is often tightly linked to host immune status,"/>
  <result pre="(OhAinle et al., 2011, Steel et al., 2010). More fit" exact="DENV" post="strains have been proposed to pose increased risk of"/>
  <result pre="target cells and resultant exacerbated cytokine cascade: (1) More pathogenic" exact="DENV" post="strains replicate more productively in human cells and thereby"/>
  <result pre="to higher titers (Cologna and Rico-Hesse, 2003); (2) more pathogenic" exact="DENV" post="strains may evade host adaptive, cross-reactive immune responses (Kochel"/>
  <result pre="infected cells. Also inappropriate cross-reactive adaptive immune response during sequential" exact="DENV" post="infection may lead to the more severe immunopathogenesis, that"/>
  <result pre="2012). Finally, differences in the breadth of diversity of circulating" exact="DENV" post="genomes during acute infection (&quot;intrahost diversity�?) have been hypothesized"/>
  <result pre="addition to mutations that may alter the replicative ability of" exact="DENV" post="viruses in human cells, some viruses may also be"/>
  <result pre="reduced neutralization by the host humoral (antibody-mediated) response. The four" exact="DENV" post="serotypes all have the ability to cause severe and"/>
  <result pre="determining disease outcome (OhAinle et al., 2011). In interepidemic periods," exact="DENV" post="is thought to be maintained in endemic populations through"/>
  <result pre="virus may undergo significant evolution. Also it is seen that" exact="DENV" post="evolves over a single epidemic season, such that viruses"/>
  <result pre="factor for the development of severe disease and death from" exact="DENV" post="infection. Many studies indicate that the incidence of DSS"/>
  <result pre="2000). Host genetics play a vital role in susceptibility to" exact="DENV" post="infection and studies show that people with an African"/>
  <result pre="to protect against the development of clinical disease from secondary" exact="DENV" post="infection (Stephens et al., 2002). Also, HLA-A*A24 was overrepresented"/>
  <result pre="al., 2008). Several other gene polymorphisms are also associated with" exact="DENV" post="infection few such are tumor necrosis factor (TNF)-308A allele"/>
  <result pre="factor (TNF)-308A allele and increased susceptibility to severe manifestations of" exact="DENV" post="infection (Perez et al., 2010), and a possible protective"/>
  <result pre="a possible protective association between the TNF-238A allele and severe" exact="DENV" post="infection (Garcia et al., 2011) and increased frequency of"/>
  <result pre="gene appeared to be protected from the development of severe" exact="DENV" post="infection. Viral binding to platelets via human platelet antigens"/>
  <result pre="The G allele of DC-SIGN1-336 appears to protect against milder" exact="DENV" post="infection, DF, but not against more serious disease (Sakuntabhai"/>
  <result pre="in patients with immunological evidence of a previous history of" exact="DENV" post="exposure or, in the case of infants, those with"/>
  <result pre="phase of IgM production followed by IgG. During a primary" exact="DENV" post="infection, antidengue IgM levels will begin to rise 3–5"/>
  <result pre="its functional avidity for the whole virion. T-Cell Responses in" exact="Dengue" post="Infection T cells recognize short antigenic peptides bound in"/>
  <result pre="has helped us in understanding the T-cell response in a" exact="DENV" post="person. Using these techniques, a large number of epitopes"/>
  <result pre="al., 2010, Kurane et al., 1989). T-Cell Responses in Secondary" exact="Dengue" post="Infection Many of the T cells induced in the"/>
  <result pre="al., 2011, Mongkolsapaya et al., 2006). Innate Immune Responses in" exact="Dengue" post="Virus Infection DENV counteracts two important elements of innate"/>
  <result pre="et al., 2006). Innate Immune Responses in Dengue Virus Infection" exact="DENV" post="counteracts two important elements of innate immunity, namely, the"/>
  <result pre="involved in antiviral innate immune responses are targeted by DENV." exact="DENV" post="has been shown to trigger complement activation in vitro"/>
  <result pre="vivo (Avirutnan et al., 2006). Complement likely functions to limit" exact="DENV" post="infection by stimulating adaptive immune responses and by neutralizing"/>
  <result pre="in vitro and in vivo can paradoxically enhance replication of" exact="DENV" post="(Balsitis et al., 2010, Zellweger et al., 2010). Complement"/>
  <result pre="also augments antibody-mediated neutralization of flaviviruses, including YFV, DENV, and" exact="WNV" post="(Mehlhop et al., 2009). In myeloid cells that express"/>
  <result pre="(Cardosa et al., 1983). Antibody and complement-dependent opsonization may augment" exact="DENV" post="infection in myeloid cells. In early clinical studies, reduced"/>
  <result pre="C3 and C1q were observed, particularly in patients with severe" exact="DENV" post="disease during secondary infection (Bokisch et al., 1973). In"/>
  <result pre="leakage (Malasit, 1987). DENV-infected cells may display sufficient amounts of" exact="DENV" post="antigens (prM, E, or NS1 proteins) on their surface"/>
  <result pre="response elements that have antiviral activity (Kawai and Akira, 2007)." exact="DENV" post="has been reported to be sensed by several TLRs"/>
  <result pre="TLR7, RIG I and MDA5 (Nasirudeen et al., 2011). Several" exact="DENV" post="proteins had been identified as inhibitors of type I"/>
  <result pre="that would trigger the induction of hundreds of ISGs. Also" exact="DENV" post="can inhibit the production of type I IFN in"/>
  <result pre="replication, by inhibiting type I IFN production in human DCs," exact="DENV" post="may affect the quality of the adaptive immune response"/>
  <result pre="the adaptive immune response generated after infection. Clinical Features of" exact="Dengue" post="Symptomatic Dengue Following an infectious mosquito bite there is"/>
  <result pre="immune response generated after infection. Clinical Features of Dengue Symptomatic" exact="Dengue" post="Following an infectious mosquito bite there is an incubation"/>
  <result pre="resolution of the vasculopathy (Qiu et al., 1993). Factors Influencing" exact="Dengue" post="Disease Severity Children and the elderly have a lower"/>
  <result pre="with adults (Anders et al., 2011, Trung et al., 2012)." exact="Dengue" post="associated mortality also appears to be higher in pregnant"/>
  <result pre="be tested for virus/RNA/antigen detection or for serological studies. Acute" exact="Dengue" post="Diagnosis Diagnosis during the acute phase of illness allows"/>
  <result pre="sample is also useful for virus isolation. Molecular Diagnosis of" exact="Dengue" post="DENV RNA can be extracted from serum or plasma,"/>
  <result pre="is also useful for virus isolation. Molecular Diagnosis of Dengue" exact="DENV" post="RNA can be extracted from serum or plasma, as"/>
  <result pre="universal dengue primers targeting the conserved C/prM region of the" exact="DENV" post="genome for an initial reverse transcription and amplification step,"/>
  <result pre="14 (Duyen et al., 2011). Early and Late Convalescent Diagnosis" exact="Dengue" post="viremia correlates with fever onset, with peak levels at"/>
  <result pre="as secondary infection. The assays used for detecting a past" exact="DENV" post="infection are HI, IgG ELISA (Vazquez et al., 1997),"/>
  <result pre="ELISA (Vazquez et al., 1997), and neutralization assay to detect" exact="DENV" post="neutralizing antibodies (Alvarez et al., 2008). Viral Isolation and"/>
  <result pre="mammalian cell lines, VERO, BKH21, and LLC-MK2 were introduced for" exact="DENV" post="isolation. These cell lines have a low sensitivity for"/>
  <result pre="viruses. As a result, they are not used for routine" exact="DENV" post="isolation, although they are useful for the quantitative plaque"/>
  <result pre="inoculation of adult mosquitoes opened a new sensitive way for" exact="DENV" post="isolation. In addition, a method to inoculate mosquito larvae"/>
  <result pre="developed in the 1970s and 1980s provide sensitive systems for" exact="DENV" post="isolation. Three cell lines have commonly been used: AP-61"/>
  <result pre="cytometry as well as NS1 detection have been employed for" exact="DENV" post="identification (Jarman et al., 2011, Kao et al., 2001)."/>
  <result pre="(Jarman et al., 2011, Kao et al., 2001). Management of" exact="Dengue" post="Management of suspected dengue patients depends on the clinical"/>
  <result pre="in the febrile phase is mostly symptomatic and supportive treatment." exact="Dengue" post="patients usually have high sustained fever ranging from 2"/>
  <result pre="done as per existing protocols (Gubler, 2014). Prevention and Control" exact="Dengue" post="Vector Control There is little to no effective vector"/>
  <result pre="tripeptide inhibitors were synthesized to probe the dynamics of the" exact="DENV" post="protease active site with different functional groups that compete"/>
  <result pre="broad acting antivirals have been pursued (Becker et al., 2012)." exact="Dengue" post="Vaccine Development The potential use of safe and effective"/>
  <result pre="vector control could be more effective (Halstead and Deen, 2002)." exact="Dengue" post="vaccines could have beneficial individual-level effects by reducing the"/>
  <result pre="the level of immunogenicity it evokes and the attenuation of" exact="DENV" post="pathogenicity. The immunogenicity induced by the vaccine should be"/>
  <result pre="Yellow Fever Virus as Molecular Backbone Acambis/Sanofi Pasteur Vaccine (CYD)" exact="DENV" post="vaccine is based on dengue–YF vaccine virus chimeras Chimeric"/>
  <result pre="those of DENV-2 NGC. Yet another approach uses a capsid-deleted" exact="WNV" post="vector to produce DENV pseudoinfectious derivatives (Suzuki et al.,"/>
  <result pre="Yet another approach uses a capsid-deleted WNV vector to produce" exact="DENV" post="pseudoinfectious derivatives (Suzuki et al., 2009). The DENV-WNV chimeras"/>
  <result pre="2009). The DENV-WNV chimeras are expected to retain the wild-type" exact="WNV" post="attribute of high replicative efficiency enhancing the productive potential"/>
  <result pre="separately introducing 3′ terminus changes into each of the four" exact="DENV" post="or by making structural gene chimeras, including all four"/>
  <result pre="African green monkey kidney cells. Serial passage of different wild-type" exact="DENV" post="(2 DENV-1, 2 DENV-2, and 3 DENV-4) resulted in"/>
  <result pre="University of North Carolina has developed a vaccine in which" exact="DENV" post="E protein is produced by a Venezuelan encephalitis virus"/>
  <result pre="tetravalent live-attenuated dengue vaccine based on serial passage of wild-type" exact="DENV" post="in PDK cells. Among the selected passage levels, the"/>
  <result pre="Subunit Vaccines T- and B-cell epitopes have been mapped on" exact="DENV" post="structural proteins such as EDIII and NS proteins (Kurane"/>
  <result pre="effective and safe vaccine at moderate cost. Structural and NS" exact="DENV" post="proteins have been produced in adequate amounts in many"/>
  <result pre="in dengue surveillance: a report from the Asia-Pacific and Americas" exact="Dengue" post="Prevention BoardsPLoS Negl. Trop. Dis.4112010e89010.1371/journal.pntd.000089021103381 BeckerG.L.LuY.HardesK.StrehlowB.LevesqueC.LindbergI.Highly potent inhibitors of"/>
  <result pre="helicase catalytic coreVirology3282200420821810.1016/j.virol.2004.07.00415464841 BennettS.N.Taxonomy and evolutionary relationship of flavivirusesOoiE.E.GublerD.J.VasudevanS.FarrarJ.Dengue and" exact="Dengue" post="Hemorrhagic FeverVol. 322–3332014CAB International BernardoL.YndartA.VazquezS.MorierL.GuzmanM.G.Antibody responses to Asian and"/>
  <result pre="Biomed. Sci.922013616723847455 BhuvanakanthamR.ChongM.K.NgM.L.Specific interaction of capsid protein and importin-alpha/beta influences" exact="West Nile" post="virus productionBiochem. Biophys. Res. Commun.38912009636910.1016/j.bbrc.2009.08.10819712667 BiswasH.H.OrtegaO.GordonA.StandishK.BalmasedaA.KuanG.Early clinical features of"/>
  <result pre="dengue virus replicationPLoS One8122013e8250410.1371/journal.pone.008250424376541 D’ArcyA.ChailletM.SchieringN.VillardF.LimS.P.LefeuvreP.Purification and crystallization of dengue and" exact="West Nile" post="virus NS2B-NS3 complexesActa Crystallogr. Sect. F. Struct. Biol. Cryst."/>
  <result pre="two dengue infections spaced 20 years or more apart: Havana," exact="Dengue" post="3 epidemic, 2001-2002Int. J. Infect. Dis.95200528028510.1016/j.ijid.2004.07.01216023878 GrahamJ.D.A unique pig-sticking"/>
  <result pre="endemic area—Puerto Rico, 2007-2008Am. J. Trop. Med. Hyg.825201092292910.4269/ajtmh.2010.09-055220439977 GublerD.Dengue and" exact="West Nile" post="virus—an interview with Duane Gubler, Sc.D., reported by Vicki"/>
  <result pre="history and emergence as a global public health problemOoiE.E.GublerD.J.VasudevanS.FarrarJ.Dengue and" exact="Dengue" post="Hemorrhagic Fever2014CAB International GublerD.J.ClarkG.G.Dengue/dengue hemorrhagic fever: the emergence of"/>
  <result pre="promoter-dependent RNA synthesisJ. Virol.851220115745575610.1128/JVI.02343-1021471248 IglesiasN.G.BykL.A.GamarnikA.V.Molecular virology of dengue virusOoiA.P.E.E.GublerD.J.VasudevanS.FarrarJ.Dengue and" exact="Dengue" post="Hemorrhagic Fever2013CAB International334365 InnisB.L.ThirawuthV.HemachudhaC.Identification of continuous epitopes of the"/>
  <result pre="5 is required for the cellular entry of dengue and" exact="West Nile" post="virusesJ. Virol.81920074881488510.1128/JVI.02210-0617301152 KuberskiT.RosenL.ReedD.MataikaJ.Clinical and laboratory observations on patients with"/>
  <result pre="of dengue controlLancet377977820111630163110.1016/S0140-6736(11)60470-421546075 MehlhopE.FuchsA.EngleM.DiamondM.S.Complement modulates pathogenesis and antibody-dependent neutralization of" exact="West Nile" post="virus infection through a C5-independent mechanismVirology39312009111510.1016/j.virol.2009.08.01919744691 MenR.WyattL.TokimatsuI.ArakakiS.ShameemG.ElkinsR.Immunization of rhesus"/>
  <result pre="Natl. Acad. Sci. U.S.A.109362012146101461510.1073/pnas.121237910922908290 SchullerA.YinZ.Brian ChiaC.S.DoanD.N.KimH.K.ShangL.Tripeptide inhibitors of dengue and" exact="West Nile" post="virus NS2B-NS3 proteaseAntiviral Res.92120119610110.1016/j.antiviral.2011.07.00221763725 SeetR.C.QuekA.M.LimE.C.Post-infectious fatigue syndrome in dengue"/>
  <result pre="Trop. Med. Hyg.875201279680510.4269/ajtmh.2012.12-001923033404 ShepardD.S.HalasaY.A.UndurragaE.A.Economic and disease burden of dengueOoiE.E.GublerD.J.VasudevanS.FarrarJ.Dengue and" exact="Dengue" post="Hemorrhagic Fever2014CAB International ShurtleffA.C.BeasleyD.W.ChenJ.J.NiH.SudermanM.T.WangH.Genetic variation in the 3′ non-coding"/>
  <result pre="sequences of the genome and replicative-from RNA of the flavivirus" exact="West Nile" post="virus: absence of poly(A) and possible role in RNA"/>
  <result pre="XuZ.AndersonR.HobmanT.C.The capsid-binding nucleolar helicase DDX56 is important for infectivity of" exact="West Nile" post="virusJ. Virol.851120115571558010.1128/JVI.01933-1021411523 YangH.LiZ.LinH.WangW.YangJ.LiuL.A novel dengue virus serotype 1 vaccine"/>
 </snippets>
</snippetsTree>
